dbl™ docetaxel, concentrated injection
pfizer new zealand limited - docetaxel 10 mg/ml - solution for infusion - 10 mg/ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol macrogol 300 nitrogen as needed polysorbate 80 - treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. dbl docetaxel, concentrated injection in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. dbl™ docetaxel, concentrated injection in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress her2 and who previously have not received chemotherapy for metastatic disease.
docetaxel sandoz
novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for infusion - 20 mg/2ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol nitrogen polysorbate 80 - metastatic breast cancer docetaxel sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. docetaxel sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.
docetaxel sandoz
novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for infusion - 80 mg/8ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol nitrogen polysorbate 80 - metastatic breast cancer docetaxel sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. docetaxel sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.
docetaxel hospira 10 mg/ml inf. sol. (conc.) i.v. vial
hospira benelux bv-srl - docetaxel 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - docetaxel trihydrate - docetaxel
docetaxel hospira 10 mg/ml inf. sol. (conc.) i.v. vial
hospira benelux bv-srl - docetaxel 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - docetaxel trihydrate - docetaxel
docetaxel hospira 10 mg/ml inf. sol. (conc.) i.v. vial
hospira benelux bv-srl - docetaxel 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - docetaxel trihydrate - docetaxel
docetaxel sandoz 10 mg/ml inf. sol. (conc.) i.v. vial
sandoz sa-nv - docetaxel 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - docetaxel anhydrous - docetaxel
docetaxel sandoz 10 mg/ml inf. sol. (conc.) i.v. vial
sandoz sa-nv - docetaxel 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - docetaxel anhydrous - docetaxel
docetaxel sandoz 10 mg/ml inf. sol. (conc.) i.v. vial
sandoz sa-nv - docetaxel 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - docetaxel anhydrous - docetaxel
docetaxel ebewe
novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for injection - 20 mg/2ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol macrogol 300 polysorbate 80